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E-mail: jon.otter@imperial.nhs.ukIntroductionMultidrug-resistant Gram-negative bacteria (MDR-GNB) pre-
sent an important and increasing threat to healthcare world-
wide [1,2]. Due to the heterogeneity of microorganisms and
resistance types within MDR-GNB, there are considerable
differences in the scope and structure of available guidelines
(Table 1). The quality of the evidence-base for determining
which is the most effective intervention for the prevention and
control of MDR-GNB is generally low [3–5]. Evidence from
outbreak settings is unreliable, and studies that have been
performed in endemic settings with a single intervention are
usually of low-quality [3,4]. A recent study concluded that a
single intervention was more likely to fail than a bundled© 2015 Clinical Microbiology and Infection published by Elintervention (failure rate 45% versus 28%, odds ratio 1.9) [6].
However, this does not help in determining the relative impact
of each element of the bundle. Here, we review European
guidelines on MDR-GNB written in English, analysing the
guidelines in terms of scope, setting, organism, evidence syn-
thesis and interventions, aiming to identify areas of controversy
to inform future research.
All European guidelines on MDR-GNB written in English
were reviewed in detail, and recommendations were aligned
and compared.
Broad areas of agreement
Infection prevention and control interventions can be classiﬁed
as either ‘universal’ (sometimes referred to as ‘horizontal’, for
example antimicrobial stewardship) or ‘targeted’ (sometimes
referred to as ‘vertical’, for example screening and isolation)
[7,8]. Some have argued for a move from targeted to universal
interventions for methicillin-resistant Staphylococcus aureus and
vancomycin-resistant enterococci [8]. However, of note, all
MDR-GNB guidelines advocate a targeted approach. Fig. 1 il-
lustrates the broad areas of agreement for the variousClin Microbiol Infect 2015; 21: 1057–1066
sevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases
http://dx.doi.org/10.1016/j.cmi.2015.09.021
TABLE 1. Overview of guidelines for multidrug-resistant Gram-negative bacteria
Guideline Organisms/groups included Setting(s) Deﬁnition of ‘MDR’
ESCMID 2014 [3] ESBL-Enterobacteriaceae
MDR Klebsiella pneumoniae
MDR Acinetobacter baumannii
MDR Pseudomonas aeruginosa
Burkholderia cepacia
Stenotrophomonas maltophilia
Acute-care facilities,
endemic or epidemic
Non-susceptibility to at least one agent in
three or more antimicrobial categories
(CDC/ECDC deﬁnition) [66]
Irish MDRO 2012 [29] Resistant Enterobacteriaceae
CRE
MDR A. baumannii
MDR P. aeruginosa
Acute-care facilities, long-term
care and community
Resistant to one or more agents in three or
more different classes of antimicrobials that
the isolate is expected
to be susceptible to
Public Health England
CPE 2013 [67]
CPE Acute-care facilities —
Health Protection Scotland
CPE 2013 [68]
CPE Acute-care facilities —
ECDC Systematic Review
2014 [4]
CPE Acute-care facilities,
long-term care
—
Guidelines including various ‘MDR-GNB’ (ECCMID and Irish MDRO) use a very similar deﬁnition of ‘MDR’, following closely the ECDC/CDC deﬁnition of ‘non-susceptibility to at
least one agent in three or more antimicrobial categories’ [66].
Abbreviations: CPE, carbapenemase-producing Enterobacteriaceae; CRE, carbapenem-resistant Enterobacteriaceae; ECDC, European Centre for Disease Prevention and Control;
ESBL, extended-spectrum β-lactamase; ESCMID, European Society of Clinical Microbiology and Infectious Diseases; GNB, Gram-negative bacteria; MDR, multidrug-resistant;
MDRO, multidrug-resistant organisms.
1058 Clinical Microbiology and Infection, Volume 21 Number 12, December 2015 CMIinterventions. All guidelines agree that hand hygiene, contact
precautions, single rooms and note ﬂagging should be applied in
some capacity for all pathogens (included in the guideline) in all
settings; recommendations for the other interventions vary by
pathogen and setting. Guidelines for each organism-group are
summarized in Table 2.H
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FIG. 1. Overview of recommendations by guideline, setting and organism.
Clinical Microbiology and Infectious Diseases guidelines; green squares = re
mentioned or no recommendation.
© 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalf of European SocHand hygiene
Few studies have evaluated the impact of hand hygiene
improvement on the transmission of MDR-GNB [9–11].
Reinforcing hand hygiene compliance is commonly considered
to be a key intervention to bring outbreaks of MDR-GNB un-
der control [3,4,12].sc
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TABLE 2. Comparison of recommendations
Recommendation
MDR Acinetobacter baumannii MDR Pseudomonas aeruginosa ESBL-Enterobacteriaceae Highly-resistant Enterobacteriaece/CRE
ESCMID
Irish
MDRO ESCMID
Irish
MDRO ESCMID
Irish
MDRO ESCMID
Irish
MDRO PHE HPS ECDC
All E All E All E All E All E All E All E All E All E All E All E
Hand hygiene
education (HH)
R(S) R R(S) R R(S) R R(S) R R R R
Contact
precautions
(CP)
R(S) R R(S) R R(S) R R(S) R NR [i] R R
Audit adherence to
CP
R(S) R(S) R(S) R(S)
Consider droplet
precautions in
ICU settings and
for all AGP
NE R(C) NR NE NR NE NR NE NR
Discontinue CP
(ceasing to apply
CP)
NE NE NR NE NR NE NR NE NR NR
Pre-emptive CP for
high-risk patients
R(S) NE NE R(C) R(C) R(S) R(C) R(S) R
Single room R(S) R R(C) R(S) R R(C) R(S) R R(S) R R R R
Pre-emptive single
room isolation for
high-risk patients
R R R
Discontinue
isolation room
NR NR NR NR NR NR
Risk assessment to
manage limited
isolation rooms
R R R R
Environmental
cleaning
R(S) R(C) R(C) R(C) R R
Enhanced
environmental
cleaning
R(S) R R(C) R R(S) R(C) R
Decontaminate
equipment
appropriately
R(S) R(C) R(C) R(C) R
Consider changing
point of use ﬁlters
on taps
Terminal
disinfection using
hypochlorite
NR
Consider hydrogen
peroxide vapour
as an adjunctive
measure
S S S S NR
Environmental
screening
R(C) NR R R(C) NR R R(C) NR S R(C) NR S
Antimicrobial
stewardship
R(C) R R(C) R R(S) R(S) R R(C) R(C) R R R
Active
Surveillance
Cultures (ASC)
R(S) R(S) NR S R(S) S R(S) R R
Continued on next page
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TABLE 2. Continued
Recommendation
MDR Acinetobacter baumannii MDR Pseudomonas aeruginosa ESBL-Enterobacteriaceae Highly-resistant Enterobacteriaece/CRE
ESCMID
Irish
MDRO ESCMID
Irish
MDRO ESCMID
Irish
MDRO ESCMID
Irish
MDRO PHE HPS ECDC
All E All E All E All E All E All E All E All E All E All E All E
Screen previous
positives on
admission
R(S) NE NE R(C) R(C) R(S) R R(C) R(S) R R R
Screening specimen
should include a
rectal, peri-rectal
or stool sample
R(S) R R(S) R R(S) R R(S) R R R
Screen patients
admitted to high-
risk units
(e.g. ICU)
S S S S S S S
Implement weekly
screening on high-
risk units
S S S S S S R R S
Screen patients that
are considered
high-risk
S S R S S S R R R
Screen contacts of
new cases
(“contact
tracing”)
R R R R R
Communication
Note ﬂagging/alert
code
R(S) NE R NE R(C) R R(C) R(S) R R(C) R(S) R R R R
Notify carriage
status for internal/
external transfers
R(S) R(S) R(S) R(S) R
Education R(S) R(C) R R(C) R R(C) R(S) R R(C) R R R
Multidisciplinary
incident
management team
R(C) R R(C) R R(C) R(S) R R(C) R R R
Prompt notiﬁcation
of IPCT when
resistant bacteria
are identiﬁed
R R R R
Infection prevention
and control
infrastructure
NE R(C) NE NE S R(C) S R(C)
Patient informed of
their carriage
status and given
appropriate
patient
information
R R R R
Cohort patients R(C) R(C) R(C) R(C) R R
Cohort staff R(C) S R(C) S R(C) S R(S) R R R
Monitor hand
hygiene
compliance when
patient cohorting
is applied
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© 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalf oThere is general agreement in all of the guidelines for all
organism-groups that clear hand hygiene guidelines should be in
place and that education programmes should be implemented.
There is also agreement that alcohol-based hand hygiene products
are suitable for hand hygiene following direct patient contact or
contact with their environment on most occasions [3].
Contact (and droplet) precautions and single rooms
Contact precautions, deﬁned herein as the use of personal pro-
tective equipment such as gloves and gowns and clear signage, can
be delivered in either a multi-occupancy bay or single-room
setting. There is evidence from studies in endemic settings that
applying contact precautions can help to prevent the transmission
of MDR-GNB [4,13–18]. The use of single rooms for patients
with MDR-GNB is a distinct but related intervention. Several
studies performed in the endemic setting have shown that
switching from a multi-occupancy conﬁguration to single rooms
results in a reduction in MDR-GNB transmission [19–21].
Most guidelines recommend the provision of a single room
and contact precautions for patients known to be infected or
colonized with MDR-GNB. The European Society of Clinical
Microbiology and Infectious Diseases (ESCMID) recommenda-
tion for contact precautions includes a recommendation to
audit adherence [3]. The demand for single rooms will outstrip
supply in countries with a low proportion of single rooms [22],
and the Irish multidrug-resistant organisms (MDRO) guidelines
include a recommendation to manage a limited stock of single
rooms through risk assessment.
There is less agreement on pre-emptive contact precautions
and single rooms for high-risk patients who are not yet known
to be colonized or infected with MDR-GNB; and whether to
discontinue contact precautions and single rooms. No studies
have evaluated the impact of pre-emptive contact precautions
or single rooms as single interventions in preventing the
transmission of MDR-GNB.
Discontinuation of single rooms is not recommended for any
pathogen in any setting by the Irish MDRO and the UK
carbapenemase-producing Enterobacteriaceae (CPE) guidelines.
Colonization with MDR-GNB usually persists for the duration
of hospitalization and often for months following discharge,
which suggests that patients with a history of MDR-GNB
colonization should be considered at high risk of continued
colonization [23–28].
Consideration of droplet precautions (the use of a mask for
patient contact) is recommended for intensive care unit settings
and all aerosol-generating procedures by ESCMID for Acineto-
bacter baumannii in epidemic settings, and not recommended in
the Irish MDRO guidelines for any organism in any setting [3,29].
There is evidence that A. baumannii can be aerosolized in the
intensive care unit [30] and that Pseudomonas aeruginosa can bef European Society of Clinical Microbiology and Infectious Diseases, CMI, 21, 1057–1066
1062 Clinical Microbiology and Infection, Volume 21 Number 12, December 2015 CMIreleased as an aerosol by patients with cystic ﬁbrosis [31], which
offers some basis for these recommendations/suggestions.
Cleaning/disinfection
Enhanced cleaning and disinfection are frequently used as MDR-
GNB outbreak control measures, but there are limited data in
endemic settings that improved cleaning and disinfection reduce
the transmission of MDR-GNB [32–35]. The various guidelines
take a different approach to recommendations surrounding
cleaning and disinfection. The ESCMID guidelines are most
comprehensive, offering a series of best-practice and speciﬁc
recommendations, which can be divided into ‘basic’ measures
for all settings, and ‘enhanced’ measures for outbreaks
(Table 3). Meanwhile, the Irish MDRO and various CPE
guidelines make fewer but more speciﬁc recommendations
surrounding environmental cleaning and disinfection.
Enhanced cleaning is recommended by ESCMID, Irish
MDRO, European Centre for Disease Prevention and Control
(ECDC) and Public Health England (PHE) CPE guidelines for all
pathogens in outbreak settings. Surprisingly, switching to a
bleach disinfectant is not recommended by any guidelines; in
fact, the PHE CPE guidelines speciﬁcally recommend against
modifying the currently used detergent or disinfectant. The
Irish MDRO guidelines recommend considering hydrogen
peroxide vapour (HPV) for dealing with persistently contami-
nated surfaces [29]; HPV has been shown to be superior to
conventional methods in addressing contamination withTABLE 3. European Society of Clinical Microbiology and In
recommendations
Environmental Scree
Basic
Implement regular environmental cleaning procedures,
which include detergents or disinfectants, depending on
local practice to reduce the transmission rate.
Use a
wa
con
Ensure cleaning of patient care equipment and the environment.
When available, dedicate non-critical medical items for use on individual patients
Shared equipment should be disinfected between use on different patients.
Enhanced
Vacate units for intensive cleaning. Imple
pre
Review use of disinfectant agents, methods and meticulousness of cleaning,
dilutions and contact time of the hospital cleaning procedures.
Scree
per
e.g.
Implement environmental cleaning procedures with audit and feedback The f
mic
Specify in protocols which items are to be disinfected, which disinfectant to use,
and how often items need to be disinfected.
Consi
all
or
Dedicate the use of non-critical patient-care equipment to a single patient
or cohort of patients
Admi
fee
Speciﬁc protocols for the disinfection of endoscopes and respiratory equipment
should be implemented locally.
Period
hig
the
Consider closure of the ward or the unit to new admissions in order also to
facilitate cleaning until there is evidence of control of transmission.
Befor
ens
Abbreviations: ASC, active surveillance cultures; ICU, intensive care unit; MDR-GNB, multid
© 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalf of European SocMDRGNB, and may reduce MDR-GNB transmission
[33,35–36]. Switching to bleach for disinfection is commonly
implemented in outbreak settings but no studies have evaluated
the impact of switching to bleach as a single intervention for
MDR-GNB in endemic settings [32,36].
There is general agreement that environmental screening
should not be performed routinely in endemic settings but may
be useful during outbreaks.
Antimicrobial stewardship
There is evidence from a number of intervention studies that
restriction of antimicrobial use reduces rates of antibiotic
resistance and incidence of A. baumannii, P. aeruginosa and
extended-spectrum β-lactamase-producing Enterobacteriaceae
(ESBL-E) [37–41]. Antimicrobial stewardship is recommended
by the ESCMID, Irish MDRO, ECDC and PHE CPE guidelines
but it is not listed as a speciﬁc recommendation in the Health
Protection Scotland (HPS) CPE guidelines.
Active surveillance cultures
Few studies have evaluated the impact of active surveillance cul-
tures (ASC), sometimes known as ‘patient screening’, as a single
intervention in endemic settings to control MDR-GNB [11,42].
ASC is regularly included as a part of bundles that have been
implemented in endemic and epidemic settings [43–49].
Recommendations surrounding ASC are perhaps the cause
for most controversy between the guidelines, both in terms offectious Diseases ESCMID environmental and screening
ning
lert code to identify promptly patients already known as colonized at hospital/
rd admission and perform screening and pre-emptive
tact precautions.
ment a programme of ASC at hospital admission followed by contact
cautions.
ning cultures should use stool samples or swab samples from the rectum or
i-rectal area as well as samples from the inguinal area and manipulated sites,
catheters and areas of broken skin such as wounds.
requency of screening cultures should be based on the local prevalence of the
roorganism, patient colonization risk, and the case mix of the unit.
der performing ASC at the time of hospital admission for high-risk patients or for
patients in high-risk units such as cancer or ICU wards, according to local incidence
prevalence data.
ssion, discharge and weekly patient screening might also be considered to provide
dback to healthcare workers and to assess the effectiveness of interventions.
ic (e.g. weekly) ASC might be performed for patients remaining in the hospital at
h risk for carriage of MDR-GNB because of ward type (ICU), prolonged antibiotic(s)
rapy, underlying disease, long duration of stay, presence of devices and surgery.
e transferring patients to other healthcare facilities (acute and non-acute care)
ure communication of status.
rug-resistant Gram-negative bacteria.
iety of Clinical Microbiology and Infectious Diseases, CMI, 21, 1057–1066
CMI Otter et al. Guidelines controversies for MDR-GNB control in EU 1063structure and details. There is agreement that screening spec-
imens for MDR-GNB should include a rectal, peri-rectal or
stool specimen, with a rectal sample usually recommended for
resistant Enterobacteriaceae. The ESCMID guidelines make a
large number of broad recommendations, which are designed
to be tailored to speciﬁc settings (Table 3). Meanwhile, the Irish
MDRO and various CPE guidelines make fewer, more speciﬁc
recommendations.
Most guidelines recommend screening previous positive
cases at the time of hospital re-admission for most MDR-GNB.
All guidelines do not recommend ASC for A. baumannii,
P. aeruginosa and ESBL-E in endemic settings, whereas ASC is
recommended in all settings for CPE and in outbreaks for the
other organisms. The ESCMID guidelines do not include spe-
ciﬁc recommendations for CPE, but do not recommend ASC
outside of outbreak settings for MDR Klebsiella pneumoniae,
which would include CPE. One surprising omission from the
ESCMID guidelines surrounding ASC is the lack of recom-
mendations around ‘contact tracing’, which is recommended in
some settings in most other guidelines.
Communication, education, infrastructure and
organizational preparedness
Education has not been evaluated as a single intervention and
yet most guidelines recommend some level of education,
especially in outbreak settings. Appropriate communication
between various departments and between hospitals and other
healthcare facilities has not been evaluated as a single inter-
vention. However, a focus on communication, especially ﬂag-
ging of patient notes, is common.
Infection prevention and control infrastructure and organi-
zational preparedness are addressed in detail in the ESCMID and
PHE CPE guidelines, but not in detail in the other guidelines.
Cohorting staff/patients
No intervention studies in an endemic setting have addressed
cohorting staff or patients as a single intervention. Staff
cohorting is challenging, and only feasible with nursing staff in
most settings because of the need for physicians to visit multiple
patients.
ESCMID, the Irish MDRO and PHE CPE guidelines recom-
mend both staff and patient cohorting during outbreaks only,
whereas ECDC recommends staff cohorting in all settings, and
patient cohorting in outbreaks only.
Screening healthcare workers and home contacts
Screening healthcare workers and home contacts has not been
evaluated as a speciﬁc intervention in endemic settings. The
Irish MDRO and PHE CPE guidelines recommend against
screening healthcare workers whereas the ESCMID and HPS© 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalf oCPE guidelines recommend healthcare worker screening during
outbreaks for some organisms.
Patient decolonization
Studies of chlorhexidine daily bathing have consistently failed to
demonstrate a reduction in MDR-GNB, perhaps due to under-
powering [11,50–52]. Chlorhexidine bathing is a common con-
stituent of GNB outbreak bundles [12,53,54], although reduced
susceptibility has been reported [55,56]. The Irish MDRO
guidelines recommending chlorhexidine bathing during outbreaks
of ESBL-E and CPE, and ESCMID for MDR K. pneumoniae during
outbreaks. ECDCCPE guidelines advocate antiseptic bathing in all
settings. In contrast, chlorhexidine bathing is not recommended in
any setting in the PHE and HPS CPE guidelines.
Selective digestive decontamination as a prophylactic mea-
sure in the intensive care unit reduces the acquisition of
MDRO, including MDR-GNB [57–59]. However, unsurpris-
ingly, selective digestive decontamination is also associated with
an increase in resistance [59–61]. A number of studies have
evaluated the use of antibiotics for digestive decolonization of
Gram-negative bacteria, with moderate impact [62–63]. The
PHE CPE guidelines recommend against the use of antibiotics to
attempt to decolonize patients with MDR-GNB in all settings
for all organisms; no guidelines make a positive recommenda-
tion for the use of antibiotics for decolonization.Laboratory practicesAnumber of the guidelinesmake speciﬁc recommendations about
laboratory practices, whereas others, most notably the ESCMID
guidelines, do not. The Irish MDRO guidelines are most
comprehensive from a laboratory viewpoint, recommending
speciﬁc antimicrobials to be tested against the various organism
groups, genotypic conﬁrmation of resistance mechanisms, a
retrospective review of laboratory records when a new case is
identiﬁed and recommendations around laboratory competency
[29].Recommendations from this reviewThe various controversies between the guidelines reﬂect the
poor quality of the evidence base, with guideline writers having
to rely on expert opinion. Variety in the aims of the guidelines,
and differences in methodology in producing the guidelines also
contributes to the sense of controversy [64]. However, all
agree that a multifaceted approach is required, but more
agreement on contentious issues would be useful.f European Society of Clinical Microbiology and Infectious Diseases, CMI, 21, 1057–1066
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transmission dynamics between the large and heterogeneous
groups of MDR-GNB, and what works to prevent MDR-GNB
transmission. This will require active collaborations with co-
ordination of large, multicentre intervention studies, ideally
using cluster randomization.
Implementing guidelines is challenging, especially where re-
sources are limited. National health programmes should include
a speciﬁc economic plan (with EU funding) to support hospitals
to provide resources for adequate stafﬁng and training, espe-
cially where CPE carbapenem-resistant non-fermenters are a
problem [65].SummaryA number of MDR-GNB guidelines are available in Europe,
which vary considerably in terms of their scope and structure.
A number of areas of controversy exist, including when to
apply contact precautions, single-room isolation, ASC; whether
or not to perform staff and patient cohorting, healthcare
worker screening or patient decolonization; and how best to
tackle the contaminated environment through cleaning and
disinfection. Limitations in the evidence base mean that further
research is an urgent requirement to inform the best approach
to the prevention and control of MDR-GNB.Transparency declarationET was a co-author on the ESCMID Guidelines. JAO is a
consultant to GAMA Healthcare Ltd.FundingThe research was funded by the National Institute for Health
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